在单细胞水平上了解质母细胞瘤:最近的进展和未来的挑战
Yahaya A Yabo1,2, Dieter Henrik Heiland1,2,3,4,5,6
1Translational Neurosurgery, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
PLoS biology
|May 30, 2024
概括
单细胞转录组学揭示了质母细胞瘤的异质性,有助于个性化治疗的发展. 对这些脑瘤的进一步研究将改善患者的治疗结果.
科学领域:
- 神经瘤学神经瘤学
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 质母细胞瘤是一种具有攻击性的脑瘤,以快速生长和耐治疗性而闻名.
- 瘤的异质性和可塑性推动了质母细胞瘤的进展和治疗失败.
- 在单细胞水平上了解质母细胞瘤对于开发有效的治疗方法至关重要.
研究的目的:
- 探索从单细胞转录组学中获得的洞察力,以表征质母细胞瘤.
- 突出单细胞分析在理解质母细胞瘤瘤发生,进展和耐药性的作用.
- 确定单细胞质母细胞瘤研究的持续挑战和未来方向.
主要方法:
- 单细胞转录组学应用于质母细胞瘤样本.
- 单个瘤细胞的分子特征.
- 对导致质母细胞瘤的遗传和分子特征的分析.
主要成果:
- 单细胞转录组学为质母细胞瘤的细胞和分子构成提供了前所未有的洞察力.
- 确定了导致瘤发生,疾病进展和治疗耐药性的关键特征.
- 突出了质母细胞瘤固有的异质性.
结论:
- 单细胞转录组学是剖析质母细胞瘤复杂性的强大工具.
- 克服成本和数据分析方面的挑战是临床翻译的关键.
- 单细胞技术的进步有望改善针对性治疗和改善质母细胞瘤患者的治疗结果.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...


